Marshall Wace’s Terns Pharmaceuticals TERN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-144,644
| Closed | -$399K | – | 3002 |
|
|
2025
Q1 | $399K | Sell |
144,644
-658,692
| -82% | -$1.82M | ﹤0.01% | 2050 |
|
|
2024
Q4 | $4.45M | Buy |
803,336
+698,578
| +667% | +$3.87M | 0.01% | 1020 |
|
|
2024
Q3 | $874K | Buy |
104,758
+78,773
| +303% | +$657K | ﹤0.01% | 1569 |
|
|
2024
Q2 | $177K | Sell |
25,985
-160,024
| -86% | -$1.09M | ﹤0.01% | 2109 |
|
|
2024
Q1 | $1.22M | Buy |
+186,009
| New | +$1.22M | ﹤0.01% | 1373 |
|
|
2023
Q3 | – | Sell |
-356,726
| Closed | -$3.12M | – | 2310 |
|
|
2023
Q2 | $3.12M | Buy |
356,726
+171,698
| +93% | +$1.5M | 0.01% | 1005 |
|
|
2023
Q1 | $2.19M | Buy |
185,028
+148,947
| +413% | +$1.76M | ﹤0.01% | 1134 |
|
|
2022
Q4 | $367K | Buy |
+36,081
| New | +$367K | ﹤0.01% | 1914 |
|